Cellebrite DI Ltd. CLBT
Nasdaq · stock · Services-Prepackaged Software · website · IPO 2021-08-31
Cellebrite DI Ltd. statistics & valuation
Market cap$3.4B
P / E43.8×
P / S7.2×
P / B7.1×
P / FCF21.4×
Net margin16.5%
Return on equity16.2%
FCF margin33.7%
Return on capital11.7%
Graham number -75.9%$3.68
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($3.68); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 84.2% | 84.4% | 83.6% | 81.3% | 82.7% | 80.6% |
| Operating margin | 14.0% | 14.2% | 10.2% | 0.4% | 5.6% | 4.7% |
| Net margin | 16.5% | -70.5% | -24.9% | 44.6% | 29.0% | 3.0% |
| FCF margin | 33.7% | 30.8% | 29.8% | 5.1% | 12.6% | 31.0% |
| Return on assets | 8.3% | -41.0% | -15.2% | 30.0% | 21.0% | 1.6% |
| Return on equity | 16.2% | -84.2% | -237.1% | 163.5% | -97.3% | 9.1% |
| Current ratio | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 | 2.03 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.